Artiva Biotherapeutics ARTV
NASDAQ ARTV
$7.12 +0.09 (+1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Capital Leases (2024 - 2025)

Updated

Artiva Biotherapeutics' Capital Leases was $11,000 in Q1 2025, down 75.0% from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Capital Leases (2024 - 2025) Analysis & Trends

At the end of FY2024, Capital Leases at Artiva Biotherapeutics came in at $44,000.

  • Per Business Quant data, ARTV's Capital Leases in the three quarters before Q1 2025 was $44,000 (Q4 2024), $75,000 (Q3 2024) and $106,000 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Artiva Biotherapeutics 280.62 Mn 280.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 11,000.00
Dec 31, 2024 44,000.00
Sep 30, 2024 75,000.00
Jun 30, 2024 106,000.00
API Access

Artiva Biotherapeutics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ARTV&period=max&api_key=YOUR_API_KEY